Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndromeLanlan Zhou, Xueyi Pan, Shiqiu Qiu et al.|Journal of Cancer Research and Clinical Oncology|2020Cited by 47
Education level as a predictor of survival in patients with multiple myelomaLimei Xu, Juan Li, Xiuju Wang et al.|BMC Cancer|2020Cited by 28
IL-6 and IL-10 Are Associated With Gram-Negative and Gram-Positive Bacteria Infection in LymphomaQiuhua Zhu, Xueyi Pan, Huan Li et al.|Frontiers in Immunology|2022Cited by 27